NCT02113475UnknownNot Applicable
A Patient Outcome Study After Pharmacomechanical Catheter-directed Thrombolysis and Standard Treatment for Venous Thrombosis
Heart and Vascular Outcomes Research Institute1 site in 1 country1,800 target enrollmentStarted: April 2014Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 1,800
- Locations
- 1
- Primary Endpoint
- Quality of Life,
Study Overview
Brief Summary
Deep Venous Thrombosis affects more than 350,000 individuals each year in the U.S.The Registry will track patient outcome and quality of life over 60 months for treatment with anticoagulation and elastic compression stockings and catheter-directed thrombolysis (CDT) in accordance with current treatment guidelines .
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 16 Years to 75 Years (Child, Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Data obtained in line with good clinical practice, applicable laws and regulation
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Quality of Life,
Time Frame: 60 months
Secondary Outcomes
- Rate of Post-Thrombotic Syndrome(60 Months)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Enrolling By Invitation
Not Applicable
Evaluation of Chemical Venous Thromboembolism Prophylaxis in TraumaThromboembolism, VenousNCT06025162Methodist Health System100
Unknown
Not Applicable
Thromboembolic Complications After Pacemaker or Implantable Cardioverter-Defibrillator ProceduresBradyarrhythmiasArrhythmiasCardiovascular DiseaseVenous ThrombosisPulmonary EmbolismNCT01717495University of Sao Paulo1
Unknown
Not Applicable
The DARE Warfarin CER StudyDeep Venous ThrombosisPulmonary EmbolismNCT03271450Brigham and Women's Hospital416,000
Recruiting
Not Applicable
Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)Venous ThromboembolismNCT03728166Brigham and Women's Hospital400
Completed
Phase 2
Resuscitative Endocrinology:Single-dose Clinical Uses for Estrogen-Traumatic Brain InjuryTraumatic Brain InjuryNCT00973674University of Texas Southwestern Medical Center50
